Dr. Thuy-Hong Le-Kumar, MD

Dr. Le-Kumar practices at Dothan Hematology & Oncology in Dothan, Alabama.

Dr. Le-Kumar's NPI, 1598260101, was assigned on March 26, 2018. Dr. Le-Kumar graduated from St. George's University School of Medicine in 2018. Dr. Le-Kumar holds Alabama license 48895.

Dr. Le-Kumar's primary practice is Dothan Hematology & Oncology, at 287 Healthwest Dr, Dothan, AL 36303 in Houston County. The practice phone is (334) 792-9500.

Dr. Le-Kumar's primary practice is Dothan Hematology & Oncology in Dothan, Alabama. Dr. Le-Kumar is also affiliated with Southeast Health Medical Center. The medical group on file is Dothan Hematology & Oncology. Dmand AI also links Dr. Le-Kumar to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Le-Kumar practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Le-Kumar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Le-Kumar's licenses on file in 2 states: Alabama and Minnesota.

CMS data shows 37,775 Medicare services from Dr. Le-Kumar across 26 procedure codes in 2024, for 464 Medicare patients. Medicare paid $302,895 for them. Every service was in an office.

CMS counts 464 Medicare patients who saw Dr. Le-Kumar in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Le-Kumar's median patient age at 70, with 65% women.

In 2024, Dr. Le-Kumar wrote 316 Medicare Part D claims for 129 patients. 78% of them were for generic drugs. CMS names the drug for 123 of them, across 6 drugs with 11 or more claims each, at $3,843 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Le-Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 171 general payments to Dr. Le-Kumar from 43 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 92% of the total. Janssen Pharmaceuticals, Inc paid the most, $442.

Dr. Le-Kumar graduated from St. George's University School of Medicine in 2018.

Dr. Le-Kumar is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.